Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.
about
Current and Emerging Options in the Management of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Considerations in the Elderly.Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report.[Value of Immunohistochemical Methods in Detecting EML4-ALK Fusion Mutations: A Meta-analysis].
P2860
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@ast
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@en
type
label
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@ast
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@en
prefLabel
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@ast
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@en
P2093
P2860
P1433
P1476
Epidermal Growth Factor Recept ...... onary Adenocarcinoma Patients.
@en
P2093
Jacqueline Whang-Peng
Reury-Perng Perng
Yen-Chiang Tseng
Yen-Han Tseng
Yi-Hsuan Lin
Yu-Chin Lee
Yuh-Min Chen
P2860
P304
P356
10.1634/THEONCOLOGIST.2014-0352
P577
2015-06-08T00:00:00Z